newsfilter
← Latest News
GlobeNewswire·

Kinnate Biopharma Inc. to Participate in the 2023 SVB Securities Global Biopharma Conference

SAN FRANCISCO and SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a clinical-stage precision oncology company, today announced that its chief executive officer, Nima